[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:rett-syndrome:mecp2-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Rett Syndrome","MECP2 Gene",10,[8,16,22,28,34,40,46,52,58,65],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07503444","A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome",[12],"Phase 3","RECRUITING","2026-08-26T02:18:29.369233Z","2026-05-29T15:36:40.189674Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07480564","Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to \u003C4 Years With Rett Syndrome",[12],"2026-08-03T03:01:15.394071Z","2026-05-29T15:36:40.188848Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06840496","To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome",[12],"2026-08-26T02:18:04.640417Z","2026-05-05T02:43:28.868672Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT07569445","Auditory EEG and Behavioral Assessments in Individuals With Rett Syndrome",[],"2026-08-26T02:15:46.655893Z","2026-05-13T02:55:06.732644Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT06338267","Validating Innovative Biosensors for Rett Autonomic Symptom Tracking",[],"2026-08-26T02:18:48.678868Z","2026-05-13T02:55:06.436426Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":44,"content_modified":45},"NCT05932589","Neurophysiologic Biomarkers in Rett Syndrome",[],"2026-08-26T02:15:34.659160Z","2026-05-13T02:55:06.395026Z",{"nct_id":47,"title":48,"phases":49,"status":13,"updated_at":50,"content_modified":51},"NCT05432349","Rett Syndrome Registry",[],"2026-08-26T02:15:00.557154Z","2026-05-13T02:55:06.348215Z",{"nct_id":53,"title":54,"phases":55,"status":13,"updated_at":56,"content_modified":57},"NCT04900493","The Rett Syndrome Global Registry",[],"2026-08-26T02:17:39.857430Z","2026-05-13T02:55:06.273186Z",{"nct_id":59,"title":60,"phases":61,"status":62,"updated_at":63,"content_modified":64},"NCT05898620","A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T01:57:36.164517Z","2026-05-05T02:43:28.567314Z",{"nct_id":66,"title":67,"phases":68,"status":62,"updated_at":69,"content_modified":70},"NCT05606614","A Phase 1\u002F2\u002F3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)",[12],"2026-08-03T02:05:00.744226Z","2026-05-05T02:43:28.301389Z"]